Funding for this research was provided by:
Bill and Melinda Gates Foundation
Received: 8 March 2021
Accepted: 28 October 2021
First Online: 25 November 2021
: G.A. is a founder of SeromYx Systems, Inc. and an equity holder in Leyden Labs. G.A. is a member of the scientific advisory board of Sanofi Pasteur. K.C. is a member of the scientific advisory boards of Integrum Scientific LLC, Biovaxys Technology Corp, and the Pandemic Security Initiative of Celdara Medical, LLC. K.C., M.E.D., D.H., and R.K.J., are named co-inventors on a patent application assigned to Albert Einstein College of Medicine that covers a SARS-CoV-2 surrogate neutralization assay. The remaining authors declare no competing interests.